Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Cann Group.
RELATED STOCKHEAD STORIES
Health & Biotech
Weed Week: Big win for cannabis as SAFER Banking Act approved; market remains robust in Australia
Health & Biotech
Weed Week: Short sellers burned as cannabis stocks stage a rebound. Where to next?
Health & Biotech
Weed Week: Mastercard says NO to cannabis transactions, as New York becomes the happening place for weed
Health & Biotech
ASX Health Stocks: Medibio jumps 50pc on Phase 1 results; Cann doubles cannabis harvest
Health & Biotech
ASX Health Stocks: Cann’s cannabis flower sales grow 500pc; Immuron runs out of Travelan as travel rebounds
News
Banking on pot: Minus one global investment house, Switzerland moves to legalise cannabis
Health & Biotech
Weed Week: BOD advances Aqua Phase acquisition with stability testing
Health & Biotech
ASX Health Stocks: Most biotechs are still chasing maiden revenue, but here’s a few healthcare stocks with strong earnings
Health & Biotech
Weed Week: Codeine demand drops when recreational cannabis is legal, study finds
Health & Biotech
There’s some very good resins why our Little Green Pharma is already leading the 2023 German invasion
Health & Biotech
Weed Week: Snoop Dogg releases Death Row Cannabis and Aussie player hits the German market
News
Market Highlights: Fed comments scare the market, and 5 ASX small caps to watch on Tuesday
Health & Biotech
ScoPo’s Powerplays: ASX healthcare sector Christmas rally runs out of puff
Health & Biotech
Weed Week: Aussie companies jostle to become the world’s supplier of medicinal cannabis
Health & Biotech
Weed Week: More US states vote to legalise cannabis and Czech Republic to follow in Germany’s footsteps
Health & Biotech
ASX Biotech Stocks: Medibank says nope to paying ransom for data theft
Health & Biotech
